Literature DB >> 9492000

Bcl-2 obstructs negative selection of autoreactive, hypermutated antibody V regions during memory B cell development.

S Hande1, E Notidis, T Manser.   

Abstract

We analyzed the participation of a predominant B cell clonotype in the anti-arsonate immune response of mice in which Bcl-2 expression was enforced in B cells. Many of the antibodies expressed by the arsonate-induced memory compartment of these mice were "dual-reactive," displaying increased affinity acquired via V region somatic hypermutation for both arsonate and the autoantigen DNA. The hypermutated antibodies expressed by the anti-arsonate memory B cell compartment of normal mice have increased affinity for arsonate but lack measurable affinity for DNA. Thus, interference with apoptotic pathways allows developing memory B cells that have acquired autoreactivity to bypass a peripheral tolerance checkpoint. These data demonstrate that both positive and negative selection, working in concert with V gene somatic hypermutation, result in the "specificity maturation" of the antibody response.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9492000     DOI: 10.1016/s1074-7613(00)80471-9

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  24 in total

1.  Receptor editing in peripheral B cell tolerance.

Authors:  Jeffrey S Rice; Jeffrey Newman; Chuansheng Wang; Daniel J Michael; Betty Diamond
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-19       Impact factor: 11.205

Review 2.  Activation-induced cytidine deaminase and aberrant germinal center selection in the development of humoral autoimmunities.

Authors:  Ahmad Zaheen; Alberto Martin
Journal:  Am J Pathol       Date:  2011-02       Impact factor: 4.307

3.  Aborted germinal center reactions and B cell memory by follicular T cells specific for a B cell receptor V region peptide.

Authors:  Ryan A Heiser; Christopher M Snyder; James St Clair; Lawrence J Wysocki
Journal:  J Immunol       Date:  2011-05-27       Impact factor: 5.422

4.  Enforced expression of the apoptosis inhibitor Bcl-2 ablates tolerance induction in DNA-reactive B cells through a novel mechanism.

Authors:  Ying-Hua Wang; Yi Yan; Jeffrey S Rice; Bruce T Volpe; Betty Diamond
Journal:  J Autoimmun       Date:  2011-04-01       Impact factor: 7.094

5.  Deletion of IgG-switched autoreactive B cells and defects in Fas(lpr) lupus mice.

Authors:  Djemel Aït-Azzouzene; Dwight H Kono; Rosana Gonzalez-Quintial; Louise J McHeyzer-Williams; Min Lim; Dilki Wickramarachchi; Tobias Gerdes; Amanda L Gavin; Patrick Skog; Michael G McHeyzer-Williams; David Nemazee; Argyrios N Theofilopoulos
Journal:  J Immunol       Date:  2010-06-16       Impact factor: 5.422

6.  Somatic hypermutation as a generator of antinuclear antibodies in a murine model of systemic autoimmunity.

Authors:  Wenzhong Guo; Diana Smith; Katja Aviszus; Thiago Detanico; Ryan A Heiser; Lawrence J Wysocki
Journal:  J Exp Med       Date:  2010-08-30       Impact factor: 14.307

Review 7.  Dysregulation of germinal centres in autoimmune disease.

Authors:  Carola G Vinuesa; Iñaki Sanz; Matthew C Cook
Journal:  Nat Rev Immunol       Date:  2009-12       Impact factor: 53.106

Review 8.  DNA-reactive B cells in lupus.

Authors:  Jolien Suurmond; Justine Calise; Susan Malkiel; Betty Diamond
Journal:  Curr Opin Immunol       Date:  2016-08-06       Impact factor: 7.486

9.  Estrogen alters thresholds for B cell apoptosis and activation.

Authors:  Christine M Grimaldi; James Cleary; A Selma Dagtas; Dariush Moussai; Betty Diamond
Journal:  J Clin Invest       Date:  2002-06       Impact factor: 14.808

10.  Fas receptor expression in germinal-center B cells is essential for T and B lymphocyte homeostasis.

Authors:  Zhenyue Hao; Gordon S Duncan; Jane Seagal; Yu-Wen Su; Claire Hong; Jillian Haight; Nien-Jung Chen; Andrew Elia; Andrew Wakeham; Wanda Y Li; Jennifer Liepa; Geoffrey A Wood; Stefano Casola; Klaus Rajewsky; Tak W Mak
Journal:  Immunity       Date:  2008-10-02       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.